The fourth place in Forbes list was changed, and sun piaoyang's family made a breakthrough

According to yaozhi.com, on November 7, Forbes released the "2019 Forbes China rich list" The top three are still from Ali Ma Yun, Tencent Ma Huateng and Evergrande Xu Jiayin In 2018, Wanda Wang Jianlin (156.63 billion), ranking fourth, retired to the 14th place (88.39 billion) this year In 2018, the 15th (71.76 billion) hang Rui sun piaoyang family ranked the top four with a wealth value of 182.43 billion! According to the statistics of the author, there are 49 rich people in 2019 Forbes rich list from or related to the pharmaceutical industry See the table below for details With the market value of Hengrui exceeding 400 billion this year, it seems to the outside world that Hengrui is a real "wealth making machine" In the list, we can easily find that Hengrui medicine occupies 5 seats in the top 400 of China's rich list, among which Hengrui Cen ranks 42 from 195 last year, Hengrui Dong Wei from 135 last year to 85, Hengrui Wu Yulan from 154 last year to 237, Hengrui Cai Hongbing from 197 last year Name dropped to 376, I guess the ranking may be related to the large-scale reduction of Hang Rui executives this year In addition to Hengrui, there are also a group of rich people created by the two heroes of Meirui, Dabo brothers, three heroes of Fuxing and the family of dashanlin Li Xiting and Xu hang, from Mindray medical, hold 30.48% and 27.68% respectively, ranking 27th and 29th respectively in the rich list Lin's relative brother from Dabo holds 88.58% of the company's equity in total, and is in an absolute holding position Facing the growth of domestic demand for medical equipment consumables, Dabo welcomes the dividend of the era of medical equipment, and both brothers are listed Guo Guangchang from Fosun dropped to 50 from 26 in 2018, Liang Xinjun from 110 in 2018 to 135, and Wang qunbin from 302 in 2018 to 389 The shareholding ratio of the three Kores from the great ginseng forest is "tripartite", and they are all listed this year Sulfur statement: this opinion only represents the author and does not represent the position of yaozhi.com You are welcome to exchange and supplement in the message area If you need to reprint, please be sure to indicate the author and source of the article.